from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1432/-

LFCtreatmentdescriptionclass of inhibitor

0.426

Amikacinug/mL Amikacintranslation

0.405

Cap5-10ug/mL Capreomycintranslation

0.473

Rox10-50 ug/mL Roxithromycintranslation

0.350

SM2-5 ug/mL Streptomycintranslation

1.219

Tet5-10 ug/mL Tetracyclinetranslation

-1.508

Rif0.2-5ug/mL Rifampicintranscription

-0.185

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.305

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.725

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.743

CPZ10-50 ug/mL Chlorpromazinerespiration

1.978

Clofazimine10-13 ug/mL Clofaziminerespiration

1.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.385

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.051

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.158

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.856

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.787

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.165

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.001

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.243

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.280

KCN5-20 ug/mL Potassium cyaniderespiration

0.123

NaN30.2-2 mM Sodium aziderespiration

0.167

Nigericin50 uM Nigericinrespiration

-0.304

TRC10-150 ug/mL Triclosanrespiration

0.732

TRZ10-25 ug/mL Thioridazinerespiration

1.282

Valinomycin0.5-10 uM Valinomycinrespiration

1.082

ZnSO42 mM ZnSO4respiration

0.264

menadione6-10 ug/mL Menadionerespiration

0.060

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.443

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.280

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.538

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.036

NRP_1Non-replicating persistence stage 1dosRassociated

0.278

Amp0.2mg/mL AmpicillincellWall

0.012

Cephalexin20-100 ug/mL CephalexincellWall

-0.523

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.364

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.147

EMB10-20 ug/mL EthambutolcellWall

0.122

Eta12-40 ug/mL EthionamidecellWall

-0.176

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.164

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.584

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.459

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.240

BZA0.12 mg/mL BenzamidearomaticAmides

-0.860

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.617

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.223

H2O24 mM hydrogen peroxideDNAdamaging

1.384

Levo10 ug/mL LevofloxacinDNAdamaging

-0.243

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.381

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.840

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.118

UVUV-irradiationDNAdamaging

1.962

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.898

Antimycin12.5-50 ug/mL Antimycin A?

0.560

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.657

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.280

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.350

PA8240.2-2 ug/mL PA-824?

0.184

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.258

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.672

Verapamil50 uM Verapamil?

-0.242

mercaptoethanol2 mM 2-Mercaptoethanol?

0.607

methoxatin10-20 ug/mL Methoxatin?